142 related articles for article (PubMed ID: 37668357)
1. Perceptions of Controversies and Unresolved Issues in the 2014 FIGO Staging System for Endometrial Cancer: Survey Results From Members of the International Society of Gynecological Pathologists and International Gynecologic Cancer Society.
Kayraklioglu N; Katsakhyan L; Cohen PA; Singh N; Rabban JT; Matias-Guiu X
Int J Gynecol Pathol; 2024 May; 43(3):242-252. PubMed ID: 37668357
[TBL] [Abstract][Full Text] [Related]
2. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
3. Endometrial Carcinoma, Grossing and Processing Issues: Recommendations of the International Society of Gynecologic Pathologists.
Malpica A; Euscher ED; Hecht JL; Ali-Fehmi R; Quick CM; Singh N; Horn LC; Alvarado-Cabrero I; Matias-Guiu X; Hirschowitz L; Duggan M; Ordi J; Parkash V; Mikami Y; Ruhul Quddus M; Zaino R; Staebler A; Zaloudek C; McCluggage WG; Oliva E
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S9-S24. PubMed ID: 30550481
[TBL] [Abstract][Full Text] [Related]
4. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of survival outcomes by anatomic involvement and histology with the revised 2023 International Federation of Gynecology and Obstetrics staging system for endometrial cancer.
Gravbrot N; Weil CR; DeCesaris CM; Gaffney DK; Suneja G; Burt LM
Eur J Cancer; 2024 Apr; 201():113913. PubMed ID: 38377777
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular Space Invasion for Endometrial Cancer: Undertreatment and Overtreatment Risks: A Survey of the Spanish Gynecologic Oncology Group.
Gorostidi Pulgar M; Diaz de la Noval B; Gil-Ibañez B; Lago Leal V; Jaunarena Marin I; Padilla Iserte P
Int J Gynecol Cancer; 2017 Jul; 27(6):1191-1199. PubMed ID: 28557833
[TBL] [Abstract][Full Text] [Related]
8. FIGO 2023 endometrial cancer staging: too much, too soon?
McCluggage WG; Bosse T; Gilks CB; Howitt BE; McAlpine JN; Nucci MR; Rabban JT; Singh N; Talia KL; Parra-Herran C
Int J Gynecol Cancer; 2023 Nov; ():. PubMed ID: 37935523
[TBL] [Abstract][Full Text] [Related]
9. Issues and inconsistencies in the revised gynecologic staging systems.
Cole L; Stoler MH
Semin Diagn Pathol; 2012 Aug; 29(3):167-73. PubMed ID: 23062423
[TBL] [Abstract][Full Text] [Related]
10. FIGO staging of endometrial cancer: 2023.
Berek JS; Matias-Guiu X; Creutzberg C; Fotopoulou C; Gaffney D; Kehoe S; Lindemann K; Mutch D; Concin N;
Int J Gynaecol Obstet; 2023 Aug; 162(2):383-394. PubMed ID: 37337978
[TBL] [Abstract][Full Text] [Related]
11. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
Pereira A; Pérez-Medina T; Magrina JF; Magtibay PM; Rodríguez-Tapia A; Peregrin I; Mendizabal E; Ortiz-Quintana L
Int J Gynecol Cancer; 2015 Jan; 25(1):49-54. PubMed ID: 25405578
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists.
Chambers LM; Vargas R; Michener CM
J Gynecol Oncol; 2019 May; 30(3):e35. PubMed ID: 30887757
[TBL] [Abstract][Full Text] [Related]
13. Microcystic, elongated, and fragmented pattern invasion is mainly associated with isolated tumor cell pattern metastases in International Federation of Gynecology and Obstetrics grade I endometrioid endometrial cancer.
Pelletier MP; Trinh VQ; Stephenson P; Mes-Masson AM; Samouelian V; Provencher DM; Rahimi K
Hum Pathol; 2017 Apr; 62():33-39. PubMed ID: 27864117
[TBL] [Abstract][Full Text] [Related]
14. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
15. Endometrial cancer risk factors, treatment, and survival outcomes as per the European Society for Medical Oncology (ESMO) - European Society of Gynaecological Oncology (ESGO) - European Society for Radiotherapy and Oncology (ESTRO) risk groups and International Federation of Gynecology and Obstetrics (FIGO) staging: An experience from developing world.
Gupta N; Pandey A; Dimri K; Sehgal A; Bhagat R; Suraj ; Gill G
J Cancer Res Ther; 2023; 19(3):701-707. PubMed ID: 37470597
[TBL] [Abstract][Full Text] [Related]
16. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
Kosary CL
Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
[TBL] [Abstract][Full Text] [Related]
17. An Extraordinary Location of Sentinel Lymph Nodes in a Patient with Endometrial Cancer.
Comba C; Aslan E; Vatankulu B; Tatar Z; Demir AA; Demir O
J Minim Invasive Gynecol; 2023 Aug; 30(8):613-614. PubMed ID: 37137423
[TBL] [Abstract][Full Text] [Related]
18. Ultrastaging of 'negative' pelvic lymph nodes in patients with low- and intermediate-risk endometrioid endometrial cancer who developed non-vaginal recurrences.
Gill SE; Garzon S; Multinu F; Hokenstad AN; Casarin J; Cappuccio S; McGree ME; Weaver AL; Cliby WA; Keeney GL; Mariani A
Int J Gynecol Cancer; 2021 Dec; 31(12):1541-1548. PubMed ID: 34706876
[TBL] [Abstract][Full Text] [Related]
19. Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States.
Renz M; Diver E; English D; Kidd E; Dorigo O; Karam A
J Minim Invasive Gynecol; 2020 Feb; 27(2):482-488. PubMed ID: 30980995
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
